Clinical and self breast examination remain important in the era of modern screening

Annals of Surgical Oncology

Volumn 19, Issue 5, 2012, Pages 1484-1490

  Ma, Irene ^a   Dueck, Amylou ^a   Gray, Richard ^a   Wasif, Nabil ^a   Giurescu, Marina ^a   Lorans, Roxanne ^a   Pizzitola, Victor ^a   Pockaj, Barbara ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SELF EXAMINATION; CANCER INCIDENCE; CANCER SCREENING; CANCER STAGING; CLINICAL EXAMINATION; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; RETROSPECTIVE STUDY; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; BREAST SELF-EXAMINATION; COHORT STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PHYSICAL EXAMINATION; RETROSPECTIVE STUDIES;

EID: 84862550141     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2162-9     Document Type: Article

References (37)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
2. National Cancer Institute (2011). Surveillance epidemiology and end results (SEER) stat fact sheets: breast cancer. Available: http://seer.cancer. gov/statfacts/html/breast.html. Accessed April 9, 2011.
3. Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1975-2002, National Cancer Institute. Bethesda, http://seer.cancer.gov/csr/1975- 2002/, based on November 2004 SEER data submission, posted to the SEER web site 2005. Accessed 14 April 2011.
4. Barry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353:1784-92. (Pubitemid 41549890)
5. Humphrey LL, Helfand M, Chan BKS, Woolf SH. Breast cancer screening: A Summary of the Evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:347-60. (Pubitemid 34977137)
6. Barton MB, Harris R, Fletcher SW. The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAME. 1999;282:1270-80. (Pubitemid 29468500)
7. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2009;151:716-26.
8. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151:727-37.
9. Houssami N, Irwig L, Ciatto S. Radiological surveillance of interval breast cancers in screening programmes. Lancet 2006;7:159-265.
10. Brekelmans CT, van Gorp JM, Peeters PH, Collette HJ. Histopathology and growth rate of interval breast carcinoma. Characterization of different subgroups. Cancer 1996;78:1220-8. (Pubitemid 26303887)
11. Burrell HC, Sibbering DM, Wilson ARM. Screening interval breast cancers: mammographic features and prognostic factors. Radiology. 1996;199:811-7. (Pubitemid 26157489)
12. Mathis KL, Hoskin TL, Boughey JC, et al. Palpable presentation of breast cancer persists in the era of screening mammography. J Am Coll Surg. 2010;210:314-8.
13. Haakinson DJ, Stucky CH, Dueck AC, Gray RJ, Wasif N, Apsey HA, Pockaj BA. A significant number of women present with palpable breast cancer even with a normal mammogram within 1 years. Am J Surg. 2010;200:712-8.
14. Agnese DN, Yusuf F, Wilson JL, Shapiro CL, Lehman A, Burak WE. Trends in breast cancer presentation and care according to age in a single institution. Am J Surg. 2004;188:437-9. (Pubitemid 39330554)
15. Tweedie E, Tonkin K, Kerkvliet N, Doig GS, Sparrow RK, O'Malley FP. Biologic characteristics of breast cancer detected by mammography and by palpation in a screening program: a pilot study. Clin Invest Med. 1997;20:300-7. (Pubitemid 27472721)
16. Molino A, Pavarana M, Micciolo R, et al. Comparative study of clinical, pathological and biological characteristics of symptomatic versus asymptomatic breast cancers. Ann Oncol. 2000;11:581-6. (Pubitemid 30431381)
17. Hartley MC, McKinley BP, Rogers EA, et al. Differential expression of prognostic factors and effect on survival in young (B40) breast cancer patients: a case-control study. Am Surg 2006;72:1189-95.
18. Dong W, Berry DA, Bevers TB, Kau S-W, Hsu L, Theriault R, Shen Y. Prognostic role of detection method and its relationship with tumor biomarkers in breast cancer: M.D. Anderson Cancer Center Experience. Cancer Epidemiol Biomarkers Prev 2008;17:1096-103.
19. Lowery JT, Byers T, Kittelson J, et al. Differential expression of prognostic biomarkers between interval and screen-detected breast cancers: does age or family history matter? Breast Cancer Res Treat 2011;129:211-9.
20. Mook S, Van't Veer LJ, Rutgers EJ, et al. Independent prognostic value of screen detection in invasive breast cancer. J Natl Cancer Inst. 2011;103:1-13.
21. Lin C, Buxton MB, Moore D, et al. Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial). Breast Cancer Res. Treat. doi:10.1007/s10549-011-1670-4.
22. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295:2492-502. (Pubitemid 43854964)
23. Kennecke H, Yerushalmi R, Woods R, et al. Metastatic behavior of breast cancer subtypes. J Clin Oncol. 2010;28:3271-7.
24. Kirsh VA, Chiarelli AM, Edwards SA, O'Malley FP, Shumak RS, Yaffe MJ, Boyd NF. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario Breast Screening Program. J Natl Cancer Inst 2011;103:942-50.
25. Porter PL, El-Bastawissi AY, Mandelson MT, et al. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 1999;91:2020-8.
26. Cowan WK, Angus B, Gray JC, Lunt LG, Ramedan Al-Tamimi R. A study of interval breast cancer within the NHS breast screening programme. J Clin Pathol. 2000;53:140-6.
27. Shen Y, Yang Y, Inoue LYT, Munsell MF, Miller AB, Berry DA. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. J Natl Cancer Inst. 2005; 97:1195-203. (Pubitemid 41258225)
28. Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353:1773-83. (Pubitemid 41549889)
29. Pisano ED, Hendrick RE, Yaffe MJ, et al. Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology. 2008;246:376-83.
30. Kelemen LE, Pankratz VS, Sellers TA, et al. Age-specific trends in mammographic density: the Minnesota Breast Cancer Family Study. Am J Epidemiol. 2008;167:1027-36. (Pubitemid 351601250)
31. Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356:227-36. (Pubitemid 46143226)
32. Carney PA, Steiner E, Goodrich ME, Dietrich AJ, Kasales CJ, Weiss JE, MacKenzie T. Discovery of breast cancers within 1 year of a normal screening mammogram: how are they found? Ann Fam Med. 2006;4:512-8. (Pubitemid 44916076)
33. Smith RA, Cokkinides V, Brooks D, Saslow D, Shah M, Brawley OW. Cancer screening in the United States, 2011: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2011;61:8-30.
34. Wilke LG, Broadwater G, Rabiner S, et al. Breast self-examination: defining a cohort still in need. Am J Surg. 2009;198:575-9.
35. McDonald S, Saslow D, Alciati MH. Performance and reporting of clinical breast examination: a review of the literature. CA Cancer J Clin. 2004;54:345-61. (Pubitemid 40073991)
36. Chiarelli AM, Majpruz V, Brown P Theriault M, Shumak R, Mai V. The contribution of clinical breast examination to the accuracy of breast screening. J Natl Cancer Inst. 2009;101:1236-43.
37. Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009;151:738-47.